Hide Board Information

Show Board Information

Intuitive Machines, Inc. LUNR

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/24/2025 11:47:55 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 6

Intuitive Machines, Inc. (NASDAQ: LUNR) Stock Message Board

1. LUNR Company Profile

    

2. LUNR Time & Sales

    

3. LUNR Recent News

    

4. LUNR Filings

    

5. LUNR Financials

    

6. LUNR Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

4	$LUNR Q4 FY24 Earnings Recap	EarningsCentral	03/24/2025 11:47:55 PM
3	$LUNR Hod8.98 f62.3M	znewcar1	09/27/2024 11:50:39 AM
2	$LUNR double tops >8 Board Views Today:	znewcar1	09/19/2024 10:34:55 AM
1	$LUNR hod7.65 then looks for a double bottom S?	znewcar1	09/19/2024 9:44:43 AM

Recent Articles

• March Earnings Report Reveals Growth for Small Businesses
• International Governance Report Set to Transform Political Insight
• Markets4you Named Most Innovative Trading App and Cost Cuts
• Reju Collaborates with Rematrix to Transform Textile Waste
• Jacobs Receives Major Environmental Services Contract with USAF
• Revolutionizing Legal Practice with Anytime AI's Latest Platform
• United Solar Holding Welcomes Binyam Giorgis as CFO
• Iveco Group Shareholders Approve Key Resolutions at AGM
• American Tungsten Celebrates Executive Order Supporting Critical Minerals
• Garrett Motion Announces Conference Call for Q1 2025 Results
• Avicanna's Management Cease Trade Order Successfully Revoked
• LAVA Therapeutics Secures Strategic Waiver Boosting Financial Health
• NextGen Digital Focuses on Long-Term Growth with Innovative Strategies
• Geomega Announces Progress on Innovative Bauxite Valorization
• South Bow Corp Safely Resumes Operations on Keystone Pipeline
• Key Highlights from Coop Pank AS's Annual Shareholder Meeting
• Celebrating Innovation: Global Health Leaders Honored
• Autoliv's Innovative Bernoulli Airbag Module Earns Recognition
• Abbott's Positive First Quarter Results and Future Outlook
• PleoPharma, Inc. Secures Key Patent for Cannabis Treatment
• Empowering Shareholders: The Future of TransCode Therapeutics
• Colombia's Successful Tender Offer for Global Bonds Due 2026
• Silvercorp Expands Production Goals and Cost Management Strategy
• Celebrating Global Health Innovators at Abu Dhabi Event 2025
• Empowering Future Babysitters with Red Cross Training Course
• MEXC Exchange Welcomes PAWS with a Strategic Listing
• BriaCell's Innovative Therapy Shows Promise for Breast Cancer Care
• UAB Energy Investments Reveals Financial Statements for 2024
• Paladin Energy Initiates Defense Against Class Action Lawsuit
• Mill Creek Residential Breaks Ground on Modera Weston Homes
• Exploring Leadership Challenges and Solutions for Local Governments
• Innovative Biotech Firm 28 Capital Begins New Journey
• Autoliv Innovates with Recognition for Safety Enhancements
• Draganfly Appoints Paul Goldenberg to Enhance Public Safety Strategies
• Innovative Research Highlights NT219's Effectiveness Against Cancer
• ISC Champions Shareholder Interests Against Plantro's Tender
• Rivalry Corp. Reports Notable Q1 2025 Performance Growth
• Spectral Medical Celebrates Tigris Trial's Enrollment Success
• Tonix Pharmaceuticals Highlights Innovations in Vaccine Development
• Cannara Biotech Announces Q2 2025 Financial Results Date
• INmune Bio Advances with CORDStrom™ Patent Milestone
• Madrigal Pharmaceuticals Leadership Transition and Future Goals
• U.S. Energy Corp. Strengthens Position with Strategic Acquisition
• Tilray Brands Proudly Ranks Among America's Top Craft Brewers
• Aya Gold & Silver Completes Strategic Deal with Mx2 Mining
• EyePoint Pharmaceuticals Enhances Talent with Stock Options Grant
• Sprott Physical Copper Trust Shifts to Prominent OTCQX Market
• Cullinan Therapeutics Initiates Phase 1 Trial for CLN-978
• Q32 Bio's Trial Progress Attracts Attention in Autoimmune Research
• Rogers Communications Optimizes Senior Notes for Growth Strategies